Completed NA INTERVENTIONAL 2-arm NCT04173039

Anti-Carbamylated Protein Antibodies in Psoriatic Arthritis (CARPAPA)

Diagnostic Value of Antibodies Against Carbamylated Proteins in Psoriatic Arthritis.

Sponsor: Association pour la Recherche Clinique et Immunologique

Conditions Arthritis, Psoriatic Psoriasis

Interventions Serum anti-CarP antibodies detection

Updated 4 times since 2019 Last updated: Nov 21, 2019 Started: Aug 29, 2018 Primary completion: Apr 24, 2019 Completion: Apr 24, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Arthritis, Psoriatic and Psoriasis and is currently completed. Association pour la Recherche Clinique et Immunologique leads this study, which shows 4 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Dec 2019 — Jan 2021 [monthly]

Completed NA

First recorded

Aug 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Association pour la Recherche Clinique et Immunologique

Data source: Association pour la Recherche Clinique et Immunologique

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pierre-Bénite, France